Skip to main content
# Title Department Research Member Research Year
81 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Asmaa Mohamed Zahran Omar 2024
82 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2024
83 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Department of Pathology Dr. Shimaa Hassan Shabaan Hassan 2024
84 Assessment of Response to Hormonal Therapy by Serum Ki-67 as a Biomarker in Non-metastatic Hormone Positive Breast Cancer Department of Medical Oncology Zeina Omar Attia Sayed 2024
85 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2024
86 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2024
87 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Dr. Marwa Tammam Ameen Hammam 2023
88 Effect of Transcranial Direct Current Stimulation of Motor Cortex versus Insula Cortex on Chronic Post-Mastectomy Pain: Randomized Sham-Controlled Trial Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2023
89 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Abdelrahman Kamel Fathy Mohammed 2023
90 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2023